NYSE:CHEHealthcare
Chemed (CHE) Valuation Check After Jefferies Downgrade And Roto Rooter And VITAS Profitability Concerns
Chemed (CHE) shares came under pressure after Jefferies cut its rating, highlighting profitability concerns in the Roto-Rooter segment, along with projected Medicare Cap revenue limitations for the VITAS hospice business in Florida.
See our latest analysis for Chemed.
At a share price of $444.74, Chemed’s recent 1 day share price return of a 1.94% decline and 7 day share price return of a 3.09% decline sit against a 1 year total shareholder return of a 17.52% decline. This suggests pressure...